Drug
Bortezomib
Bortezomib: highest development phase Phase 3, developed by Pierre Fabre, Sanofi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pierre Fabre, Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| bortezomib (Velcade ®) NCT01916252 | Phase 3 | Multiple Myeloma |
| Bortezomib NCT00714246 | Phase 1 | Non Small Cell Lung Cancer |
Latest
No recent events.
Follow Bortezomib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.